Banfi, C. http://orcid.org/0000-0003-3346-9879
Baetta, R. http://orcid.org/0000-0001-7190-4638
Barbieri, S. S.
Brioschi, M. http://orcid.org/0000-0003-4706-4418
Guarino, A.
Ghilardi, S.
Sandrini, L.
Eligini, S.
Polvani, G.
Bergman, O. http://orcid.org/0000-0003-4323-8150
Eriksson, P.
Tremoli, E.
Funding for this research was provided by:
Ministero della Salute (RF-2013-02355543, Ricerca Corrente ID 2755301 MPP 1A)
Forskningsrådet om Hälsa, Arbetsliv och Välfärd (12660)
Hjärt-Lungfonden (20180451)
Article History
Received: 27 November 2020
Accepted: 2 September 2021
First Online: 21 September 2021
Competing interests
: We disclose the following European Patent application, under examination, EP15817414.4 entitled “Prenylcysteine oxidase 1 inhibitors for the prevention and/or treatment of oxidative stress-related degenerative diseases and prenylcysteine oxidase 1 as diagnostic marker”, applicant Centro Cardiologico Monzino IRCCS, inventors C.B., M.B., R.B, and S.B., with no financial competing interest. The remaining authors declare no competing interest.